Jul 10, 2026 08:34AM
Jun 22, 2026 02:00AM
Jun 12, 2026 06:09PM
Apr 22, 2026 01:09AM
Apr 22, 2026 01:05AM
Feb 17, 2026 08:30AM
Jan 23, 2026 01:00AM Press Release: Sanofi's amlitelimab confirms its potential in atopic dermatitis
Dec 23, 2025 09:16AM
Dec 23, 2025 09:06AM
Dec 19, 2025 02:21PM
Nov 25, 2025 01:00AM
Oct 28, 2025 02:00AM
Oct 20, 2025 07:30AM
Oct 20, 2025 07:30AM Press Release: Sanofi’s Tzield accepted for expedited review in the US for stage 3 type 1 diabetes through FDA Commissioner's National Priority Voucher pilot program
Oct 2, 2025 08:00AM
Sep 22, 2025 01:00AM
Aug 29, 2025 05:50PM
Jul 22, 2025 11:57AM
Jun 2, 2025 05:40AM
Jun 2, 2025 01:25AM
May 21, 2025 07:15PM Press Release: Sanofi to acquire Vigil Neuroscience, Inc., adding a new investigational medicine to treat Alzheimer’s disease to the neurology pipeline
May 14, 2025 12:30PM
Apr 30, 2025 07:00AM
Apr 21, 2025 04:05PM
Apr 18, 2025 11:15AM
Apr 8, 2025 01:10PM
Mar 28, 2025 04:07PM
Mar 28, 2025 02:34PM Regeneron (REGN, Sanofi (SNY): Dupixent Approved as the First-ever Biologic Medicine in Japan for Patients with COPD
Mar 28, 2025 02:00AM
Mar 14, 2025 02:18PM
Feb 19, 2025 01:30AM
Dec 9, 2024 02:06PM
Nov 15, 2024 12:59AM
Nov 14, 2024 11:42AM
Nov 6, 2024 01:00AM Dupixent® (dupilumab) Approved in the European Union as the First and Only Medicine for Young Children with Eosinophilic Esophagitis
Oct 21, 2024 01:30AM
Oct 17, 2024 02:35AM
Oct 16, 2024 12:26PM
Oct 16, 2024 06:00AM
Sep 27, 2024 09:35AM
Sep 27, 2024 07:01AM
Sep 27, 2024 07:00AM Dupixent® (dupilumab) Approved in China as the First-ever Biologic Medicine for Patients with Chronic Obstructive Pulmonary Disease (COPD)
Sep 20, 2024 06:36PM
Sep 13, 2024 12:16PM
Sep 13, 2024 12:15PM
Sep 12, 2024 02:37AM
Jul 10, 2024 04:10PM
Jun 20, 2024 08:00AM
May 30, 2024 09:01AM Press Release: Sanofi completes acquisition of Inhibrx, Inc.
May 10, 2024 02:15AM

326,046 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All